Table 2: Salivary organic protective components in patients with reflux esophagitis (RE) and control group (CTRL) (Mean ± SEM)

 Parameter

 Basal

 Mastication

 Tubing

 Balloon

 Initial NaCl

 HCl

 HCl/pepsin

 Final NaCl

Glycoconjugate RE  (mg/min)

0.56 ±0.09 ⃰

1.04 ±0.16 ⃰

5.43 ±1.27 

5.21 ±0.91 ⃰

5.87 ±0.97 

7.14 ± 1.03 

7.18 ± 1.19 

6.92 ± 0.97 

Glycoconjugate CTRL  (mg/min)

0.75 ± 0.08

1.50 ± 0.20

8.30 ± 0.99

12.67 ± 1.59

11.68 ± 1.68

9.16 ± 1.32

11.75 ± 1.70

11.19 ± 1.65

Protein RE  (mg/min)

2.14 ± 0.24

3.13 ± 0.37

5.29 ± 0.88

6.10 ± 1.26

5.82 ± 1.29 

6.40 ± 1.19   

6.23 ± 1.39

5.96 ± 1.09

Protein CTRL  (mg/min)

1.77 ± 0.26

3.47 ± 0.44

6.69 ± 0.72

7.96 ± 0.83

7.60 ± 0.89

8.75 ± 1.06

7.11 ± 0.88

6.72 ± 0.75

TGFa RE  (ng/min)

0.08 ± 0.04

0.14 ± 0.03

0.18 ± 0.07

0.22 ± 0.11

0.19 ± 0.05

0.19 ± 0.03

0.19 ± 0.05

0.23 ± 0.07

TGFa CTRL  (ng/min)

0.08 ± 0.03

0.20 ± 0.07

0.21 ± 0.08

0.28 ± 0.05

0.18 ± 0.04

0.22 ± 0.04

0.24 ± 0.06

0.17 ± 0.03

PGE2 RE  (pg/min)

105 ± 42.70

279 ± 124.00

217 ± 64.40

262 ± 73.80

313 ± 94.00

314 ± 116.00

389 ± 115.00

227 ± 61.10

PGE2 CTRL  (pg/min)

65 ± 13.90

179 ± 50.40

182 ± 38.60

246 ± 58.30

161 ± 30.90

165 ± 62.50

230 ± 94.70

146 ± 36.40

                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 * = p<0.05; **= p<0.01 respectively, significant p values in patients with RE when compared to CTRL group.